Tag: pharmaceuticals
-
Antibody Discovery Company Forms, Partners on Covid-19
A new enterprise formed to discover human therapeutic antibodies is partnering with a synthetic biology company to discover Covid-19 antibody treatments.
-
Biotechs, Pharmas Vow Not to Rush Covid-19 Vaccines
In a joint statement today, CEOs of nine companies promised to follow the highest ethical and scientific standards in development and testing of their Covid-19 vaccines.
-
Small Antibody Shown to Block Covid-19 Infection
Researchers in Sweden found a small-scale antibody grown in an alpaca that in lab tests blocks the SARS-CoV-2 infection mechanism.
-
Infographic – Willingness to Take Covid-19 Vaccine
The chart shows data from surveys by polling company Ipsos MORI in 27 countries at the end of July and beginning of August, for the World Economic Forum.
-
Sanofi, GSK Begin U.S. Covid-19 Vaccine Trial
Global drug makers Sanofi and GlaxoSmithKline are starting a clinical trial testing a vaccine to prevent Covid-19 infections among healthy adults in the U.S.
-
Trial Shows Some ALS Drug Benefit for Patients
Results from a clinical trial show a drug to treat amyotrophic lateral sclerosis slows the functional decline in ALS patients compared to a placebo.
-
Synthetic Antibodies Neutralize Covid-19 Virus Proteins
A company developing synthetic genetic materials and proteins says independent tests show its artificial antibodies neutralize infection mechanisms in Covid-19 viruses.
-
NIH Nixes Convalescent Plasma Covid-19 Therapy
An expert panel convened by National Institutes of Health says current data do not support recommending convalescent plasma as a treatment for Covid-19 infections.
-
Late-Stage Covid-19 Vaccine Trial Underway in U.S.
Global drug maker AstraZeneca is starting its late-stage Covid-19 vaccine clinical trial in the U.S., with a vow not to cut corners in its processes.
-
Food Allergy Biotech Acquired for $2.6B
Aimmune Therapeutics Inc., a developer of food allergy drugs, was acquired today by global consumer products company Nestlé for $2.6 billion.